BamSEC and AlphaSense Join Forces
Learn More

Candel Therapeutics Inc.

NASDAQ: CADL    
Share price (12/23/24): $8.63    
Market cap (12/23/24): $280 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.19
from 10-K 9 pages Consulting Agreement
12/34/56
EX-10.1
from 10-Q 9 pages Amendment to Exclusive License Agreement
12/34/56
EX-10
from 10-K 43 pages Master Production Services Agreement
12/34/56
EX-10.1
from 10-Q 13 pages Employment Agreeement
12/34/56
EX-10.1
from 10-Q 13 pages Employment Agreeement
12/34/56
EX-10.8
from 10-Q 13 pages Employment Agreeement
12/34/56
EX-10.13
from 10-K 10 pages Revised Consulting Agreement – Effective October 1, 2021
12/34/56
EX-10.12
from 10-K 24 pages Employment Agreeement
12/34/56
EX-10.10
from S-1/A 56 pages Lease of Premises at 117 Kendrick Street, Needham, Massachusetts From 117 Kendrick De, LLC to Advantagene, Inc. D/B/a Candel Therapeutics
12/34/56
EX-10.9
from S-1/A 39 pages Certain Confidential Portions of This Exhibit Have Been Omitted and Replaced With “[***]”. Such Identified Information Has Been Excluded From This Exhibit Because It Is (I) Not Material and (II) Would Likely Cause Competitive Harm to the Company if Disclosed. the Brigham and Women’s Hospital, Inc. Exclusive Patent License Agreement Bwh Agreement No: [***] Bwh Case No: [***], [***], and [***]
12/34/56
EX-10.7
from S-1/A 23 pages Article 1 Definitions
12/34/56
EX-10.6
from S-1/A 34 pages Candel Therapeutics, Inc. Form of Director Indemnification Agreement
12/34/56
EX-10.5.6
from S-1/A 9 pages Consulting Agreement
12/34/56
EX-10.5.5
from S-1/A 12 pages Employment Agreeement
12/34/56
EX-10.5.4
from S-1/A 13 pages Employment Agreement
12/34/56
EX-10.5.3
from S-1/A 17 pages Amended and Restated Employment Agreement
12/34/56
EX-10.5.2
from S-1/A 18 pages Amended and Restated Employment Agreement
12/34/56
EX-10.5.1
from S-1/A 16 pages Employment Agreement
12/34/56
EX-10.4
from S-1/A 13 pages Candel Therapeutics, Inc. 2021 Employee Stock Purchase Plan
12/34/56
EX-10.3
from S-1/A 3 pages Candel Therapeutics, Inc. Senior Executive Cash Incentive Bonus Plan
12/34/56